Gelonghui, December 8 | Guohai Securities Research Report points out that American Health (002044.SZ) has launched a stock options incentive plan, making concerted efforts to create a new American year. The incentive plan is conducive to fully mobilizing the enthusiasm of the company's directors, executives, middle level cadres and core cadres, ensuring the achievement of the company's development strategy and business goals, and effectively combining the interests of shareholders, the company, and the interests of the core team. The company is a leader in private health examinations in China. Since this year, it has entered a benign development channel driven by demand and rising volume and price. It is optimistic about the value of the company's preventive medicine platform in the medium to long term. Maintain a “buy” rating.

- Headlines
- Research Report Nuggets: Guohai Securities: Maintaining the “buy” rating of American Health, optimistic about the value of the company's preventive medicine platform in the medium to long term
研报掘金丨国海证券:维持美年健康“买入”评级,中长期看好公司预防医学平台价值
Research Report Nuggets: Guohai Securities: Maintaining the “buy” rating of American Health, optimistic about the value of the company's preventive medicine platform in the medium to long term
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Price
Log In for the Full List
Latest
10:46
The Hong Kong stock market's Autos Sector strengthened, with Xpeng Motors rising over 5% to reach a new peak for this phase.
XPEV+2.63%
10:45
Hong Kong stocks continue to rise, the Hang Seng Index has turned positive, the Hang Seng TECH Index is up over 1%, and Kuaishou has risen over 6%.
Hang Seng TECH Index+0.86%
10:43
According to the data released by Shanghai Ganglian E-Commerce Holdings, the price of battery-grade lithium carbonate (morning session) increased by 100 yuan compared to the previous day, with an average price of 75,400 yuan/ton.
Shanghai Ganglian E-Commerce Holdings+2.32%
Investment Course

Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
How to view Tesla's performance in January 2025? Pay attention to these four key points.
It's earnings season for US stocks again. The performance of giant companies not only affects their own stock prices but also influences the overall trend of th
In 【2024.11】, surged more than 0.04 million times, achieving the title of stock god Buffett! How do you view Berkshire's performance?
When it comes to legendary figures in the investment world, the name of Warren Buffett, the helm of Berkshire Hathaway, is definitely unavoidable. $Berkshire Ha
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.